|
Anaplastic
(Undifferentiated) Carcinoma of Thyroid |
|
|
|
CLINICAL FEATURES |
-
2-5% of all thyroid carcinomas,
more prevalent in areas where goiter is endemic.
-
Mean age 70 years, M:F=1:1.1-1.2.
-
Clinical presentations: rapid
growth or sudden enlargement of a long standing goiter, often
associated with hoarseness, vocal cord paralysis, dysphagia and
pain.
|
|
GROSS FINDINGS |
|
|
|
MICROSCOPIC FINDINGS |
-
Highly pleomorphic epithelioid,
spindle and giant cells.
-
Coagulative necrosis, frequent
mitoses, commonly extensive neutrophilic infiltrate and
aggregate.
-
Characteristic vascular permeation
with tumor obliteration of the vascular lumen.
-
With adequate sampling, 50-90%
cases contain differentiated thyroid carcinoma.
|
|
SUBTYPES |
|
|
|
DIFFERENTIAL DIAGNOSES |
-
Angiosarcoma: usually epithelioid
cells with binucleation, rare multinucleated giant cells;
positive for CD31, CD34, and factor VIII.
-
Reidel thyroiditis: dense sclerotic
inflammation, lack of pleomorphism, atypical mitoses or ghosted
vessels.
|
|
IMMUNOHISTOCHEMISTRY AND SPECIAL STAINS |
-
Cytokeratin 40-100%
-
EMA 50%
-
Vimentin 50-100%
-
P53 70%
-
Thyroglobulin and TTF-1 usually
negative, except the residual differentiated carcinoma
-
Negative for calcitonin, HMB45,
neuroendocrine markers
|
|
ELECTRON MICROSCOPIC FINDINGS |
|
|
|
CYTOGENETIC STUDIES |
|
|
|
TREATMENT AND PROGNOSIS |
-
50% of cases are inoperable with
regional lymph node or distant metastasis.
-
Most patients survive less than one
year, mean survival 4-6 months.
|
|
REFERENCES |
|
|